1 May 2016 - The PBAC treatment algorithm for anti-HER2 therapies for treating metastatic breast cancer has been updated to reflect recent changes to restrictions for lapatinib and transtuzumab emtansine.

For more details, go to: http://www.pbs.gov.au/news/2016/05/treatment-algorithm-pdf/treatment-algorithm-for-anti-her2-therapies.pdf